共 213 条
[1]
Magill SS(2014)Multistate point-prevalence survey of health care–associated infections N Engl J Med 370 1198-1208
[2]
Edwards JR(2006)Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome Crit Care 10 R143-1428
[3]
Bamberg W(2012)Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients Eur J Clin Microbiol Infect Dis 31 1419-531
[4]
Beldavs ZG(2006)Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital Scand J Infect Dis 38 527-235
[5]
Dumyati G(2002)Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients Clin Infect Dis 35 228-1109
[6]
Kainer MA(2009)Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature Future Microbiol 4 1103-627
[7]
Nseir S(2018)French intensive care unit organisation Anaesth Crit Care Pain Med 37 625-2533
[8]
Di Pompeo C(2017)International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT) Eur Respir J. 50 1700582-
[9]
Brisson H(2012)The Berlin definition JAMA. 307 2526-266
[10]
Dewavrin F(2016)Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society Clin Infect Dis 63 e61-381